J. Jack Lee

90.8k citations

1.1k papers · 50.3k indexed · 10 hit papers · h-index 111

Otorhinolaryngology top 0.05%
- Head and Neck Cancer Studies 64
Oncology top 0.05%
- Lung Cancer Research Studies 46
- Cancer Immunotherapy and Biomarkers 44
Cancer Research top 0.05%
- Cancer Genomics and Diagnostics 85
Pulmonary and Respiratory Medicine top 0.05%
- Lung Cancer Treatments and Mutations 118
- Lung Cancer Diagnosis and Treatment 43
Periodontics top 0.1%
Statistics and Probability
- Statistical Methods in Clinical Trials 74
Molecular Biology
- Retinoids in leukemia and cellular processes 36

Co-authors: Scott M. Lippman Waun Ki Hong Adel K. El‐Naggar Ignacio I. Wistuba Diane D. Liu Reuben Lotan Razelle Kurzrock Raghu Kalluri
Cited by: Otorhinolaryngology Oncology Cancer Research
Journals: Journal of Clinical Oncology (104 papers)Clinical Cancer Research (34 papers)Cancer Research (32 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

J. Jack Lee

1.1k papers receiving 48.8k citations

Hit Papers

10 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2021 BMC Medical Research Methodology
2019 JAMA Oncology
2019 Nature Medicine
2018 Journal of Clinical Oncology
2017 Nature
2010 Nature reviews. Cancer
2009 JNCI Journal of the National Cancer Institute
2002 International Journal of Radiation Oncology*Biology*Physics
1999 Journal of Clinical Oncology
1995 PubMed

Peers

Countries citing papers authored by J. Jack Lee

Since Specialization

Citations

This map shows the geographic impact of J. Jack Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Jack Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Jack Lee more than expected).

Fields of papers citing papers by J. Jack Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Jack Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Jack Lee. The network helps show where J. Jack Lee may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J. Jack Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Jack Lee Line = papers co-authored together J. Jack Lee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients Clinical Cancer Research ·Edwin R. Parra,Carmen Behrens,Jaime Rodriguez‐Canales,Heather Lin,Barbara Mino,Jorge Blando,Jianjun Zhang,Don L. Gibbons,John V. Heymach,Boris Sepesi,Stephen G. Swisher,Annikka Weissferdt,Neda Kalhor,Julie Izzo,Humam Kadara,César A. Moran,J. Jack Lee,Ignacio I. Wistuba	2016	103
2	Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant Accrual Clinical Cancer Research ·Chad Tang,Kenneth R. Hess,S. M.,Suzanne E. Davis,Aman U. Buzdar,Razelle Kurzrock,J. Jack Lee,Funda Meric‐Bernstam,David S. Hong	2016	9
3	TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics Molecular Cancer Therapeutics ·Jennifer J. Wheler,Filip Jankú,Aung Naing,Yali Li,Bettzy Stephen,Ralph Zinner,Vivek Subbiah,Siqing Fu,Daniel D. Karp,Gerald S. Falchook,Apostolia M. Tsimberidou,Sarina A. Piha‐Paul,Roosevelt Anderson,Daniele Cristina Oliveira,Vincent A. Miller,Roman Yelensky,J. Jack Lee,David S. Hong,Razelle Kurzrock	2016	73
4	ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer Clinical Cancer Research ·Mohamed Kabbout,Melinda Garcia,Junya Fujimoto,Diane D. Liu,Denise M. Woods,Chi‐Wan Chow,Gabriela Mendoza,Amin A. Momin,Brian P. James,Luisa M. Solis,Carmen Behrens,J. Jack Lee,Ignacio I. Wistuba,Humam Kadara	2013	116
5	Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease Molecular Cancer Therapeutics ·浩一加茂,Yurisha Goorun,William N. William,Ying Liu,Jie Ma,H. Sökjer,賢司堀江,I. Secka,Li Jiang,Jeffrey N. Myers,J. Jack Lee,Sören Jahn,Zhiyuan Zhang	2013	27
6	Prediction of Survival in Resected Non–Small Cell Lung Cancer Using a Protein Expression–Based Risk Model: Implications for Personalized Chemoprevention and Therapy Clinical Cancer Research ·Kathryn A. Gold,Edward S. Kim,Diane D. Liu,Ping Yuan,Carmen Behrens,Luisa M. Solis,Humam Kadara,David C. Rice,Ignacio I. Wistuba,Stephen G. Swisher,Wayne L. Hofstetter,J. Jack Lee,Waun Ki Hong	2013	27
7	Accelerated Approval and Breakthrough Therapy Designation: Oncology Drug Development on Speed? Clinical Cancer Research ·James C. Yao,Funda Meric‐Bernstam,J. Jack Lee,Sabine Eckhardt	2013	8
8	The ubiquitin–proteasome system: central modifier of plant signalling New Phytologist ·Ari Sadanandom,Mark Bailey,Richard Ewan,J. Jack Lee,R. PICKERING	2012	322
9	Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling Cancer Prevention Research ·Humam Kadara,Li Shen,Junya Fujimoto,Pierre Saintigny,Chi‐Wan Chow,Wenhua Lang,Ajay Kumar M,Melinda Garcia,Mohamed Kabbout,You-Hong Fan,Carmen Behrens,Hiroki Furuhashi,Li Mao,J. Jack Lee,Kathryn A. Gold,Jing Wang,Kevin R. Coombes,Edward S. Kim,Waun Ki Hong,Ignacio I. Wistuba	2012	26
10	Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis Clinical Cancer Research ·Ximing Tang,Humam Kadara,Carmen Behrens,Diane D. Liu,Yun Xiao,David C. Rice,Adi F. Gazdar,Junya Fujimoto,César A. Moran,Marileila Varella‐Garcia,J. Jack Lee,Waun Ki Hong,Ignacio I. Wistuba	2011	59
11	Differential Impacts of Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) in Epithelial IGF-Induced Lung Cancer Development Endocrinology ·Woo‐Young Kim,Mi-Jung Kim,Hojin Moon,Ping Yuan,Jin‐Soo Kim,Jong Kyu Woo,Guangcheng Zhang,Young‐Ah Suh,Lei Feng,Carmen Behrens,Carolyn S. Van Pelt,Hyunseok Kang,J. Jack Lee,Scott W. Rieder,Ignacio I. Wistuba,Ho‐Young Lee	2011	19
12	Gene Expression Profiling Predicts the Development of Oral Cancer Cancer Prevention Research ·Pierre Saintigny,Li Zhang,You-Hong Fan,Adel K. El‐Naggar,Vassiliki A. Papadimitrakopoulou,Lei Feng,J. Jack Lee,Edward S. Kim,Waun Ki Hong,Li Mao	2011	109
13	Biological Activity of Celecoxib in the Bronchial Epithelium of Current and Former Smokers Cancer Prevention Research ·Edward S. Kim,Waun Ki Hong,J. Jack Lee,Li Mao,Rodolfo C. Morice,Diane D. Liu,Carlos A. Jiménez,Georgie A. Eapen,Reuben Lotan,Ximing Tang,Robert A. Newman,Ignacio I. Wistuba,Jonathan M. Kurie	2010	39
14	Epidermal Growth Factor Receptor Expression and Gene Copy Number in the Risk of Oral Cancer Cancer Prevention Research ·Z. Chen,Pierre Saintigny,Sufi M. Thomas,Adel K. El‐Naggar,Vassiliki A. Papadimitrakopoulou,Hening Ren,Wenhua Lang,You-Hong Fan,Jianhua Huang,Lei Feng,J. Jack Lee,Edward S. Kim,Waun Ki Hong,Faye M. Johnson,Jennifer R. Grandis,Li Mao	2010	88
15	A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis Clinical Cancer Research ·Humam Kadara,Carmen Behrens,Ping Yuan,Luisa M. Solis,Diane Liu,Xuemin Gu,John D. Minna,J. Jack Lee,Edward Kim,Scott W. Rieder,Ignacio I. Wistuba,Reuben Lotan	2010	68
16	High-Dose Fenretinide in Oral Leukoplakia Cancer Prevention Research ·William N. William,J. Jack Lee,Scott M. Lippman,Jack W. Martin,Nitin Chakravarti,Hai T. Tran,Anita L. Sabichi,Edward S. Kim,Lei Feng,Reuben Lotan,Vassiliki A. Papadimitrakopoulou	2009	33
17	Elevated Epithelial Insulin-like Growth Factor Expression Is a Risk Factor for Lung Cancer Development Cancer Research ·Woo-Young Kim,Quanri Jin,Amulya Yalamanchili,Edward S. Kim,Cristopher P Mill,Dong Hoon Lee,Lei Feng,Carmen Behrens,Ludmila Prudkin,York E. Miller,J. Jack Lee,Scott M. Lippman,Waun Ki Hong,Ignacio I. Wistuba,Ho‐Young Lee	2009	60
18	Phase II Randomized, Placebo-Controlled Trial of Green Tea Extract in Patients with High-Risk Oral Premalignant Lesions Cancer Prevention Research ·Anne S. Tsao,Diane Liu,Jack W. Martin,Wang ZhiDian,J. Jack Lee,Adel K. El‐Naggar,Ignacio I. Wistuba,Kirk S. Culotta,Li Mao,Ann M. Gillenwater,Yuko M. Sagesaka,Waun Ki Hong,Vassiliki A. Papadimitrakopoulou	2009	182
19	Impact of Smoking Cessation on Global Gene Expression in the Bronchial Epithelium of Chronic Smokers Cancer Prevention Research ·Li Zhang,J. Jack Lee,Hongli Tang,You-Hong Fan,Lianchun Xiao,Hening Ren,Jonathan M. Kurie,Rodolfo C. Morice,Waun Ki Hong,Li Mao	2008	57
20	Oral Epithelium as a Surrogate Tissue for Assessing Smoking-Induced Molecular Alterations in the Lungs Cancer Prevention Research ·Manisha Bhutani,Ashutosh Pathak,You-Hong Fan,Diane D. Liu,J. Jack Lee,Hongli Tang,Jonathan M. Kurie,Rodolfo C. Morice,Edward S. Kim,Waun Ki Hong,Li Mao	2008	70

About J. Jack Lee

J. Jack Lee is a scholar working on Otorhinolaryngology, Statistics and Probability, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 1.1k papers that have together received 50.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (118 papers), Cancer Genomics and Diagnostics (85 papers), Statistical Methods in Clinical Trials (74 papers), Head and Neck Cancer Studies (64 papers), Lung Cancer Research Studies (46 papers), Cancer Immunotherapy and Biomarkers (44 papers), Lung Cancer Diagnosis and Treatment (43 papers) and Retinoids in leukemia and cellular processes (36 papers). The work is most often cited by research in Otorhinolaryngology (3.1k citations), Oncology (14.9k citations), Cancer Research (7.5k citations), Pulmonary and Respiratory Medicine (11.4k citations) and Periodontics (1.3k citations). J. Jack Lee has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Scott M. Lippman, Waun Ki Hong, Adel K. El‐Naggar, Ignacio I. Wistuba, Diane D. Liu, Reuben Lotan, Razelle Kurzrock, Raghu Kalluri, Valerie S. LeBleu and Sujuan Yang. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer Research, Cancer and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact